Huiling Xiang

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Effect of pegylated interferon α-2b on low-density lipoprotein in patients with chronic hepatitis B.

Effect of pegylated interferon α-2b on low-density lipoprotein in patients with chronic hepatitis B.

Journal: Frontiers in medicine

Published: January 13, 2026

Construction of a Nomogram for Portal Vein Thrombosis After Endoscopic Therapy of Severe Gastroesophageal Varices in Cirrhotic Patients.

Construction of a Nomogram for Portal Vein Thrombosis After Endoscopic Therapy of Severe Gastroesophageal Varices in Cirrhotic Patients.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: December 18, 2025

The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B.

The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B.

Journal: Frontiers in immunology

Published: September 19, 2025

Real-World Evidence on the Efficacy of Icaritin for Unresectable Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Real-World Evidence on the Efficacy of Icaritin for Unresectable Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Journal: International journal of cancer

Published: August 23, 2025

Hepatosplenic Volumes and Portal Pressure Gradient Identify One-year Further Decompensation Risk Post-transjugular Intrahepatic Portosystemic Shunt.

Hepatosplenic Volumes and Portal Pressure Gradient Identify One-year Further Decompensation Risk Post-transjugular Intrahepatic Portosystemic Shunt.

Journal: Journal of clinical and translational hepatology

Published: May 04, 2025

Endoscopic variceal ligation combined with carvedilol versus endoscopic variceal ligation combined with propranolol for the treatment of oesophageal variceal bleeding in cirrhosis: study protocol for a multicentre, randomised controlled trial.

Endoscopic variceal ligation combined with carvedilol versus endoscopic variceal ligation combined with propranolol for the treatment of oesophageal variceal bleeding in cirrhosis: study protocol for a multicentre, randomised controlled trial.

Journal: BMJ open

Published: April 27, 2025

Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB-TACE combined with lenvatinib and camrelizumab.

Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB-TACE combined with lenvatinib and camrelizumab.

Journal: Frontiers in immunology

Published: January 02, 2025

Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study.

Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study.

Journal: Frontiers in immunology

Published: November 15, 2024

Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.

Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.

Journal: Frontiers in immunology

Published: October 27, 2024

Expression of 10 circulating cytokines/chemokines in HBV-related liver disease.

Expression of 10 circulating cytokines/chemokines in HBV-related liver disease.

Journal: Infectious agents and cancer

Published: February 19, 2024

The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis.

The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis.

Journal: Nature medicine

Published: February 19, 2024

Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis.

Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis.

Journal: JHEP reports : innovation in hepatology

Published: January 11, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026